Cargando…
Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development—A Drug Developer's Perspective
Psychiatric diseases have the lowest probability of success in clinical drug development. This presents not only an issue to address the unmet medical needs of patients, but also a hurdle for pharmaceutical and biotech industry to continue R&D in this disease area. Fundamental pharmacokinetic an...
Autor principal: | Zhu, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873432/ https://www.ncbi.nlm.nih.gov/pubmed/33584358 http://dx.doi.org/10.3389/fpsyt.2020.562660 |
Ejemplares similares
-
Editorial: The development of biomarkers in psychiatry
por: Nakano, Takashi, et al.
Publicado: (2022) -
Decision Models and Technology Can Help Psychiatry Develop Biomarkers
por: Barron, Daniel S., et al.
Publicado: (2021) -
Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives
por: Weston-Green, Katrina
Publicado: (2022) -
Grand Challenges and Opportunities for Molecular Psychiatry Research: A Perspective
por: Li, Ming D.
Publicado: (2010) -
Prospects for Future Methodological Development and Application of Magnetoencephalography Devices in Psychiatry
por: Hironaga, Naruhito, et al.
Publicado: (2020)